MDBPF Stock Chart & Stats
$3.90
$0.00(0.00%)
At close: 4:00 PM EDT
$3.90
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$2.78 - $3.92
Previous CloseN/A
Volume422.00
Average Volume (3M)0.00
Market Cap
$8.61B
Enterprise Value$13.94K
Total Cash (Recent Filing)$570.40M
Total Debt (Recent Filing)$273.90M
Price to Earnings (P/E)19.7
Beta0.59
Next Earnings
Feb 24, 2027EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend Yield3.53%
Share Statistics
EPS (TTM)0.23
Shares Outstanding2,754,003,200
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)5.63
Price to Sales (P/S)1.47
P/FCF Ratio22.70
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$3.52Price Target Upside-9.86% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)0.18
Revenue Forecast (FY)$6.93B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthSteady revenue expansion indicates continued demand for Medibank’s private health insurance and related services. A growing premium base can support operating scale, strengthen customer reach, and provide a durable platform for earnings growth over the next several quarters.
Conservative Balance SheetVery low leverage gives Medibank meaningful financial resilience and flexibility. Strong returns on equity also show that the company is using shareholder capital efficiently, supporting reinvestment, distributions, and the ability to manage changing claims or operating conditions.
Strong Earnings-to-Cash ConversionFree cash flow tracking net income supports the quality of reported earnings and indicates that profits are generally translating into cash. This strengthens the company’s capacity to fund operations, maintain capital resilience, and return money to shareholders over time.
Bears Say
Operating Profit VolatilityVolatile operating profit suggests that earnings remain sensitive to pricing, claims, and healthcare cost cycles. This can make future margins less predictable and may limit the consistency of earnings growth, even while revenue continues to rise across the business.
Volatile Cash GenerationLarge year-to-year swings in operating and free cash flow reduce confidence in the timing and consistency of internally generated funds. This variability can complicate capital planning and make distributions or investment decisions more dependent on individual reporting periods.
Leverage Has Drifted HigherAlthough leverage is still modest, its upward drift warrants monitoring because additional debt can gradually reduce financial flexibility. If profitability softens, higher obligations could place more pressure on capital management and constrain future allocation choices.
Medibank Private News
MDBPF FAQ
What was Medibank Private Ltd.’s price range in the past 12 months?
Medibank Private Ltd. lowest stock price was $2.78 and its highest was $3.92 in the past 12 months.
What is Medibank Private Ltd.’s market cap?
Medibank Private Ltd.’s market cap is $8.61B.
When is Medibank Private Ltd.’s upcoming earnings report date?
Medibank Private Ltd.’s upcoming earnings report date is Feb 24, 2027 which is in 143 days.
How were Medibank Private Ltd.’s earnings last quarter?
Medibank Private Ltd. released its earnings results on Aug 19, 2026. The company reported $0.085 earnings per share for the quarter, beating the consensus estimate of $0.084 by $0.001.
Is Medibank Private Ltd. overvalued?
According to Wall Street analysts Medibank Private Ltd.’s price is currently Overvalued.
Does Medibank Private Ltd. pay dividends?
Medibank Private Ltd. pays a Semiannually dividend of $0.079 which represents an annual dividend yield of 3.53%. See more information on Medibank Private Ltd. dividends here
What is Medibank Private Ltd.’s EPS estimate?
Medibank Private Ltd.’s EPS estimate is 0.08.
How many shares outstanding does Medibank Private Ltd. have?
Medibank Private Ltd. has 2,754,003,200 shares outstanding.
What happened to Medibank Private Ltd.’s price movement after its last earnings report?
Medibank Private Ltd. reported an EPS of $0.085 in its last earnings report, beating expectations of $0.084. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Medibank Private Ltd.?
Currently, no hedge funds are holding shares in MDBPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medibank Private Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.52 (-9.86% Downside)
$3.52 (-9.86% Downside)
Insider Transactions
Bought Shares
Worth $47.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.16%
12-Months-Change
Fundamentals
Return on Equity
3.53%
Trailing 12-Months
Asset Growth
6.90%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Medibank Private Ltd.
Medibank Private Limited (MPL.AX) is an Australian firm offering private health insurance alongside a variety of health services. The company operates through two primary divisions. Its Health Insurance division provides a comprehensive suite of private health insurance policies, encompassing coverage for hospital treatments and supplementary benefits for services like dental, optical, and physiotherapy. This division also caters to international visitors and students with specific insurance products, all underwritten by the Medibank and ahm brands. The Medibank Health division delivers health management programs, in-home care solutions, and telehealth services, primarily serving governmental and corporate clients. Furthermore, this segment handles the distribution of travel, life, and pet insurance products. Established in 1976, Medibank Private Limited is headquartered in Docklands, Australia.
MDBPF Company Deck
MDBPF Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed positive operational momentum and strategic progress: group operating profit rose 6%, Medibank Health delivered strong double-digit revenue and profit growth, policyholder growth improved and the company completed a transformative primary care acquisition while maintaining a strong capital position and lifting the interim dividend. Headwinds exist—expense inflation, a revenue-mix shift toward lower-tier products, elevated claims dynamics in extras, negative hospital utilization (partly COVID-driven), lower investment income and competitive pressure from aggregators—but management presented mitigation plans, unchanged guidance ranges, and clear capacity to invest further in health businesses. Overall, the positives (earnings growth, Medibank Health acceleration, M&A scale, capital strength and customer engagement) outweigh the manageable near-term challenges.View all MDBPF earnings summariesMDBPF Stock 12 Month Forecast
Average Price Target
$3.52
▼(-9.86% Downside)
Technical Analysis
Ownership Overview
<0.01% Insiders
6.61% Mutual Funds
<0.01% Other Institutional Investors
83.08% Public Companies and
Individual Investors